What the analyst said
Cantor Fitzgerald analyst Colin Canfield reiterated an Overweight rating and $246 price target on SpaceX (SPCX) on August 5, 2026.
“We reiterate our PT of $246 based on our balanced approach of 50% EV/EBITDA SOTP ($338), 25% EV/ Sales SOTP ($194) and 25% DCF ($258). Our 2026E sales and adj. EBITDA estimates are materially unchanged as we assume some pull-forward of 2Q26 Connectivity and AI beat, although we now assume materially greater FCF burn for 2026E.
Our 2027E-2028E sales, adj. EBITDA and FCF estimates rise as we assume greater AI benefits.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
SPCX trades at $141. The 28 analysts who set a target in the last 3 months range from $100 to $800, with a median of $248. This $246 target is 1% below the median.
Since the note SPCX has moved +12% (from $125). 12-month window: day 104 of 365, closes on August 5, 2027.
Track record
This callOpen: SPCX has not reached $246 yet. This 12-month target is scored on August 5, 2027.
Firm track recordCantor: 78% of its 58 targets at least a year old were reached within 12 months (#17 of 28 firms). Accuracy ranking →
Cantor on SpaceX
Cantor price targets on SpaceX
3 calls from August 5, 2026 to November 17, 2026. The target went from $246 to $345 (+40%). The rating stayed Buy.
- November 17, 2026Kept the $345 targetBuy$345
- October 21, 2026Target raised from $246 (+40%)Buy$345
- August 5, 2026 This noteEarliest call shownBuy$246





